arrow
R

Rune Wiseth

St Olav's University Hospital
H指数:37
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Balance of non–Lp(a) apoB and Lp(a) with Coronary Plaque Phenotypes and MACE: Insights from PROSPECT II and CASABLANCA

非Lp(a) apoB与Lp(a)的平衡与冠状动脉斑块表型及MACE的关系:来自PROSPECT II和CASABLANCA的研究启示

2026-09-260
OA
Beta-blocker therapy and physical activity after myocardial infarction: a preplanned sub-study of the BETAMI trial

β受体阻滞剂治疗和体力活动在心肌梗死后:BETAMI试验的一项预先计划亚组研究

2026-08-110
OAAI
Prehospital resuscitative endovascular balloon occlusion of the aorta in non-traumatic out-of-hospital cardiac arrest (REBOARREST): an international, multicentre, open label, pragmatic, randomised, controlled trial

主动脉预院外复苏性腔内球囊阻断在非创伤性院外心脏骤停中的应用(REBOARREST):一项国际、多中心、开放标签、实用主义、随机对照试验

2026-05-050
OAAI
Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction

心肌梗死患者生理意义与易损斑块特征之间的关联

2025-02-240
PRE
Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI
2025-01-011
PRE
Impact of Lipidic Plaque on In-Stent and Stent Edge-Related Events After PCI in Myocardial Infarction: A PROSPECT II Substudy

脂质斑块对心肌梗死PCI术后支架内及支架边缘相关事件的影响: 前景II子研究

2024-10-010
PRE
Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II
2023-02-077
OA
Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial
2022-06-0129
OAAI
Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-SegmentElevation Myocardial Infarction Employing the SOMAscan Proteomics Platform

采用SOMAscan蛋白质组学平台对白介素6拮抗作用在非ST段抬高型心肌梗死中的作用的新见解

2020-06-1613
OAAI
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study
2019-02-0140
OAAI